AAFA Praises U.S. House Passage of the FASTER Act
November 17, 2020 21:34 ET
|
Asthma and Allergy Foundation of America
Washington D.C., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Today the House of Representatives passed H.R. 2117. Named the Food Allergy Safety, Treatment, and Research Act, it is easier known as the FASTER...
Praxis Precision Medicines Provides Update On PRAX-114 IND Submission For The Treatment Of Major Depressive Disorder
November 17, 2020 07:45 ET
|
Praxis Precision Medicines, Inc
- Praxis expects to initiate Phase 2/3 clinical trial for PRAX-114 in MDD in 1H21 - CAMBRIDGE, Mass., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a...
Receptor Life Sciences Receives Schedule I Research License from U.S. Drug Enforcement Agency
November 16, 2020 08:00 ET
|
Receptor Holding
SEATTLE, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Receptor Life Sciences announced today that the Company was granted a Schedule I research license from the United States Drug Enforcement Agency (DEA). ...
Processa Pharmaceuticals Announces Third Quarter 2020 Results, Provides Corporate Update
November 12, 2020 17:02 ET
|
Processa Pharmaceuticals Inc.
HANOVER, MD., Nov. 12, 2020 (GLOBE NEWSWIRE) -- via InvestorWire -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) (“Processa” or the “Company”), a clinical-stage biopharmaceutical company focused on...
Transition to Decentralized Clinical Trials during the Coronavirus Pandemic Is far More Nuanced than Expected, According to Tufts Center for the Study of Drug Development
November 12, 2020 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, Nov. 12, 2020 (GLOBE NEWSWIRE) -- The coronavirus pandemic has facilitated rapid adoption of decentralized clinical trial execution, with more than half of all global clinical trials now...
Receptor Life Sciences Names Gregory Mayes to Board of Directors
November 11, 2020 08:00 ET
|
Receptor Holding
SEATTLE, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Receptor Life Sciences (Receptor) today announced the appointment of Gregory T. Mayes, J.D. to its Board of Directors. Mr. Mayes is an expert in...
It’s Time To Look At UV-C Light Air Purification To Combat COVID-19 More Seriously
November 02, 2020 08:45 ET
|
Vystar Corp.
Worcester, MA and Palm Springs, CA, Nov. 02, 2020 (GLOBE NEWSWIRE) -- “It’s time to look more seriously at UV-C light air purification to help protect against airborne pathogens such as COVID-19,...
Kaival Brands Innovations Group, Inc. (OTCQB: KAVL) Announces Launch of Bidi™ Pouch, Bidi™ Vapor’s Newest Smokeless Nicotine Product
October 29, 2020 09:45 ET
|
Kaival Brands Innovations Group, Inc.
GRANT, Fla., Oct. 29, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – Kaival Brands Innovations Group, Inc. (OTCQB: KAVL) (“Kaival Brands,” the “Company,” or “we”) is a company focused on generating...
Kaival Brands Innovations Group, Inc. (OTCQB: KAVL) Announces Launch of BidiTM Pouch, BidiTM Vapor’s Newest Smokeless Nicotine Product
October 29, 2020 08:41 ET
|
Kaival Brands Innovations Group, Inc.
GRANT, Fl, Oct. 29, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – Kaival Brands Innovations Group, Inc. (OTCQB: KAVL) (“Kaival Brands,” the “Company,” or “we”), a company focused on generating...
Cerecin Announces Orphan Drug Designation from U.S. FDA for Tricaprilin in the Treatment of Infantile Spasms
October 29, 2020 08:00 ET
|
Cerecin
SINGAPORE AND DENVER, COLORADO, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Cerecin, a biopharmaceutical company focused on discovering and developing brain therapeutics, announced today that the U.S. Food...